CME/CE

Host: Andrew S. Bomback, MD, MPH Guest: Kelly B. Chen, MSN, AGACNP-BC Guest: Duvuru Geetha, MD On-demand webcast on the latest advances in diagnosing and managing patients with IgA nephropathy (IgAN), including the current data on new and emerging IgAN therapies.

Host: Andrew S. Bomback, MD, MPH Guest: Kelly B. Chen, MSN, AGACNP-BC Guest: Duvuru Geetha, MD On-demand webcast on the latest advances in diagnosing and managing patients with IgA nephropathy (IgAN), including the current data on new and emerging IgAN therapies.

Host: Anne Marie Singh, MD On-demand webcast on the role of interleukin (IL)-13 in atopic dermatitis pathophysiology and strategies for leveraging IL-13 inhibitors to address disease burden and improve patient outcomes.

Host: Emily D. Clark, DO Guest: Tracey M. Piparo, PA-C, CAQ-PMHC, DFAAPA Guest: Susan Scanland, MSN, CRNP, GNP-BC, CDP Guest: Anthony J. Viera, MD, MPH In this on-demand webcast, leading experts in brain health provide guidance for patient education, discussion, and management geared toward HCPs in primary care who are at the forefront of an aging population at risk of cognitive decline trying to...

Host: Anne Marie Singh, MD On-demand webcast on the role of interleukin (IL)-13 in atopic dermatitis pathophysiology and strategies for leveraging IL-13 inhibitors to address disease burden and improve patient outcomes.

Host: Emily D. Clark, DO Guest: Tracey M. Piparo, PA-C, CAQ-PMHC, DFAAPA Guest: Susan Scanland, MSN, CRNP, GNP-BC, CDP Guest: Anthony J. Viera, MD, MPH In this on-demand webcast, leading experts in brain health provide guidance for patient education, discussion, and management geared toward HCPs in primary care who are at the forefront of an aging population at risk of cognitive decline trying to...

Host: Praveen Akuthota, MD Guest: Anisha Dua, MD, MPH Guest: Michael E. Wechsler, MD, MMSc On-demand webcast on the latest advances in diagnosing and managing patients with eosinophilic granulomatosis with polyangiitis (EGPA), including current data on new EGPA therapies and shared decision-making strategies to help patients achieve and maintain remission.

Host: Praveen Akuthota, MD Guest: Anisha Dua, MD, MPH Guest: Michael E. Wechsler, MD, MMSc On-demand webcast on the latest advances in diagnosing and managing patients with eosinophilic granulomatosis with polyangiitis (EGPA), including current data on new EGPA therapies and shared decision-making strategies to help patients achieve and maintain remission.

Faculty: Linda Stein Gold, MD Faculty: Bruce Strober, MD, PhD This podcast reviews the International Psoriasis Council (IPC) 2025 guidance on reclassifying psoriasis severity and redefining failure of topical therapies. Clinical features such as high-impact disease sites, failure of topical treatment, or BSA >10% all factor into whether patients are candidates for systemic therapy in this new g...

Faculty: Linda Stein Gold, MD Faculty: Bruce Strober, MD, PhD This podcast reviews the International Psoriasis Council (IPC) 2025 guidance on reclassifying psoriasis severity and redefining failure of topical therapies. Clinical features such as high-impact disease sites, failure of topical treatment, or BSA >10% all factor into whether patients are candidates for systemic therapy in this new g...

Host: Erika Finanger, MD, MS Guest: Aravindhan Veerapandiyan, MD The Duchenne muscular dystrophy (DMD) treatment landscape continues to evolve, with promising therapies emerging from new insights into disease biology. This activity explores the role of aberrant histone deacetylase (HDAC) activity in DMD pathophysiology, including its impact on inflammation, muscle degeneration, adipogenesis, and f...

Host: Erika Finanger, MD, MS Guest: Aravindhan Veerapandiyan, MD The Duchenne muscular dystrophy (DMD) treatment landscape continues to evolve, with promising therapies emerging from new insights into disease biology. This activity explores the role of aberrant histone deacetylase (HDAC) activity in DMD pathophysiology, including its impact on inflammation, muscle degeneration, adipogenesis, and f...

Host: Kelly Chen, MS, LCGC Guest: Chuck Vega, MD, FAAFP Guest: Jay B. Wish, MD On-demand webcast on the pathophysiology of chronic kidney disease (CKD) and expert-informed strategies to help nephrology take the helm in integrating the latest data to provide guideline-concordant care to patients with CKD.

Host: Kelly Chen, MS, LCGC Guest: Chuck Vega, MD, FAAFP Guest: Jay B. Wish, MD On-demand webcast on the pathophysiology of chronic kidney disease (CKD) and expert-informed strategies to help nephrology take the helm in integrating the latest data to provide guideline-concordant care to patients with CKD.

Faculty: Brian Slomovitz, MD This activity focuses on optimizing multidisciplinary strategies in the guideline-driven management of cervical and endometrial cancers. Dr. Brian Slomovitz presents recent and emerging clinical data for immunotherapy-based treatment strategies, explores the role of screening and biomarkers, and emphasizes interprofessional collaboration across oncology specialties. Ca...

Faculty: Brian Slomovitz, MD This activity focuses on optimizing multidisciplinary strategies in the guideline-driven management of cervical and endometrial cancers. Dr. Brian Slomovitz presents recent and emerging clinical data for immunotherapy-based treatment strategies, explores the role of screening and biomarkers, and emphasizes interprofessional collaboration across oncology specialties. Ca...

Host: Peter A. Lio, MD Guest: Wendy Smith Begolka Guest: Elizabeth Swanson, MD, FAAD On-demand webcast of expert faculty presentation on the disease burden of pediatric atopic dermatitis and strategies for helping patients achieve disease control with systemic therapy.

Faculty: A.J. Gelderblom, MD, PhD Faculty: Michiel van de Sande, MD, PhD Faculty: Chelsea Cole, MD This online CME activity addresses interdisciplinary strategies for improving outcomes in patients with tenosynovial giant cell tumor (TGCT). Faculty review the disease spectrum, including diffuse and localized subtypes, and highlight clinical features that warrant early referral to specialists. The...

Faculty: A.J. Gelderblom, MD, PhD This online CME activity addresses interdisciplinary strategies for improving outcomes in patients with tenosynovial giant cell tumor (TGCT). Faculty review the disease spectrum, including diffuse and localized subtypes, and highlight clinical features that warrant early referral to specialists. The program examines evidence from clinical trials of CSF1R inhibitor...

Faculty: A.J. Gelderblom, MD, PhD This online CME activity addresses interdisciplinary strategies for improving outcomes in patients with tenosynovial giant cell tumor (TGCT). Faculty review the disease spectrum, including diffuse and localized subtypes, and highlight clinical features that warrant early referral to specialists. The program examines evidence from clinical trials of CSF1R inhibitor...

Faculty: A.J. Gelderblom, MD, PhD Faculty: Chelsea Cole, MD This online CME activity addresses interdisciplinary strategies for improving outcomes in patients with tenosynovial giant cell tumor (TGCT). Faculty review the disease spectrum, including diffuse and localized subtypes, and highlight clinical features that warrant early referral to specialists. The program examines evidence from clinical...

Faculty: A.J. Gelderblom, MD, PhD This online CME activity addresses interdisciplinary strategies for improving outcomes in patients with tenosynovial giant cell tumor (TGCT). Faculty review the disease spectrum, including diffuse and localized subtypes, and highlight clinical features that warrant early referral to specialists. The program examines evidence from clinical trials of CSF1R inhibitor...

Faculty: A.J. Gelderblom, MD, PhD Faculty: Michiel van de Sande, MD, PhD This online CME activity addresses interdisciplinary strategies for improving outcomes in patients with tenosynovial giant cell tumor (TGCT). Faculty review the disease spectrum, including diffuse and localized subtypes, and highlight clinical features that warrant early referral to specialists. The program examines evidence...

Faculty: A.J. Gelderblom, MD, PhD This online CME activity addresses interdisciplinary strategies for improving outcomes in patients with tenosynovial giant cell tumor (TGCT). Faculty review the disease spectrum, including diffuse and localized subtypes, and highlight clinical features that warrant early referral to specialists. The program examines evidence from clinical trials of CSF1R inhibitor...

Faculty: A.J. Gelderblom, MD, PhD This online CME activity addresses interdisciplinary strategies for improving outcomes in patients with tenosynovial giant cell tumor (TGCT). Faculty review the disease spectrum, including diffuse and localized subtypes, and highlight clinical features that warrant early referral to specialists. The program examines evidence from clinical trials of CSF1R inhibitor...